Preliminary results of a phase I/II study of the humanized anti-CD20 antibody IMMU-106 (hA20) in patients with relapsed non-Hodgkin lymphoma

Sonia Cunningham, Sabeeha Muneer, Aarati Ranganathan, Latha Shivakumar, Sagar Lonial, Tariq Mughal, James O. Armitage

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)339-341
Number of pages3
JournalClinical Lymphoma and Myeloma
Volume7
Issue number5
StatePublished - Mar 2007

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this